相关实验视频
Updated: Jul 15, 2025

10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
32.2K
基于CYP2C19表型的克洛皮多格勒的群体药理动力学-药理动力学建模,以优化基于CYP2C19表型的剂量方案:概念验证研究
Yun Seob Jung1, Byung Hak Jin2, Min Soo Park2,3
1Department of Convergence Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
CPT: pharmacometrics & systems pharmacology
|September 30, 2023
概括
人口的药理动力学-药理动力学建模可以个性化克洛皮多格雷尔剂量. 较差的CYP2C19代谢器和高基线P2Y12反应单元需要显著更高的剂量才能产生有效的抗血小板作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 药物新陈代谢 药物新陈代谢
背景情况:
- 克洛皮多格雷尔是一种抗血小板药物,对于预防心血管事件至关重要.
- CYP2C19的遗传变异影响了克洛皮多格雷尔的疗效,较差的代谢者经历了降低的抗血小板活性.
- 需要个性化剂量策略来优化克洛皮多格雷尔治疗.
研究的目的:
- 开发和验证克洛皮多格雷尔的种群药动力学-药动力学 (PK-PD) 模型.
- 评估CYP2C19表型和基线P2Y12反应单元 (PRU) 对克洛皮多格雷尔反应的影响.
- 为个性化克洛皮多格雷尔剂量提出一个框架.
主要方法:
- 利用了与36名健康男性参与者进行的一期临床试验的数据.
- 开发了一个人口PK-PD模型来预测克洛皮多格雷尔及其代谢物度.
- 纳入CYP2C19表型和基线PRU作为PK-PD模型中的共变量.
- 采用蒙特卡洛模拟来评估剂量调整.
主要成果:
- 一个两部分的PK模型描述了克洛皮多格勒和克洛皮多格勒碳酸酸,而一个一个部分的模型适合克洛皮多格勒H4.
- CYP2C19表型显著影响了克洛皮多格雷尔的新陈代谢.
- 模拟表明,低CYP2C19代谢器需要3至4倍的剂量.
- 较高的基线PRU水平需要2.5-3倍增加剂量.
结论:
- 成功开发了一个群体PK-PD模型用于clopidogrel.
- 该模型有效地整合了CYP2C19表型和基线PRU,以获得个性化的剂量见解.
- 需要进一步的临床研究来确认拟议的克洛皮多格雷尔剂量建议.
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
61
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
61
Pharmacokinetic Models: Comparison and Selection Criterion
96
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
96
Analysis of Population Pharmacokinetic Data
282
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
282
Pharmacokinetic Models: Overview
761
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
761
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
186
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
186
Model Approaches for Pharmacokinetic Data: Physiological Models
65
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
65

